Blood Cancer 61 , 16731678 (2014)
SGLT-2 receptor inhibitors for treating patients with type 2 diabetes mellitus: a systematic review and network meta-analysis
Cordavis sources biosimilars from manufacturers (the initial product was a co-branded version of Sandozs adalimumab biosimilar Hyrimoz), relabels them under the Cordavis brand, and then preferences them on CVS Caremark formularies
Tirzepatide: The First Real Fracture in the Monoculture EVIDENCE TIER, REAL-WORLD HUMAN OUTCOMES Tirzepatide was the first sign that the single-receptor era was not going to last
Increases Exercise Capacity
While we may not be part of the first wave in some of these markets, we believe our differentiated offering will provide significant cost benefits to patients and expect to gain strong momentum across many of these geographies, Sharvil Patel, MD, Zydus Lifesciences said over an analyst call post fourth quarter results